Default company panoramic image
Logo

ZSX Medical, LLC

ZSX Medical is improving women's health by making surgical closure as easy as closing a Ziplock bag.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Philadelphia, PA, US
  • Currency USD
  • Founded June 2009
  • Employees 4
  • Website zipstitch.com

Company Summary

We are a pre-clinical stage medical device company exploiting a revolution in the materials and bio-mechanical sciences that will forever change the standard-of-care in surgical procedures. The Zip-Stitch platform allows surgeons to quickly and easily achieve internal surgical closure. The benefits include faster surgery, reduced costs, reduced infection, reduced complications, and reduced adhesive disease coupled with improved healing.

Team

  • Default avatar
    Dan Mazzucco
    President & CEO

    Dan Mazzucco, Ph.D. has been in the medical device industry for 14 years. Prior to joining ZSX Medical, Dr. Mazzucco directed manufacturing, preclinical, clinical, and regulatory development at Aqumen Biopharmaceuticals, a Japanese ophthalmic biotechnology startup. Dr. Mazzucco earned a doctorate in medical and mechanical engineering from Harvard Med. School and MIT in the Division of Health Sciences and Technology.

  • Default avatar
    Eric Rugart
    Chief Operations Officer, Manager (LLC)

    Mr. Rugart is the CEO of Feta Med, Inc., an ob/gyn medical supply business. Feta Med has been doing business for 43 years, and supplies over 300 hospitals. Mr. Rugart is a Penn alum & seasoned entrepreneur. He has run several companies, including a financial service company and a biometric security technology company. He is also a seasoned investor in early-stage companies, including Nano-Pack, Lifeguard Mobile, and Crestline Technologies.

  • Default avatar
    Lou Berardi
    Manager (LLC)

    Lou Berardi serves as Manager for ZSX Medical. Mr. Berardi’s extensive pharmaceutical expertise includes significant financial, operational and M&A experience, both domestically and internationally. In the last 15 years as Executive VP of Corporate Development, Mr. Berardi has spearheaded the sale of three companies – Roberts Pharmaceutical (1999), ESP Pharma (2005) and Esprit Pharma (2007) – for approximately $2 billion.

Advisors

  • Default avatar
    Saul Ewing, LLP
    Lawyer
    Unconfirmed
    Default avatar
    Jennifer Anderson, LLC
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Feta Med/Founders
    Unconfirmed
    Default avatar
    2 high net worth investors/angels
    Unconfirmed
    Default avatar
    3 vendors
    Unconfirmed